Phenotypic and genotypic evaluation of fluoroquinolone resistance in clinical isolates of Staphylococcus aureus in Tehran

Medical Science Monitor

Volumn 17, Issue 9, 2011, Pages

  Aligholi, Marzieh ^a   Mirsalehian, Akbar ^a   Halimi, Shahnaz ^a   Imaneini, Hossein ^b   Taherikalani, Morovat ^c   Jabalameli, Fereshteh ^a   Asadollahi, Parisa ^c   Mohajer, Babak ^a   Abdollahi, Alireza ^a   Emaneini, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

^c ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Fluoroquinolone resistance; QRDR; Staphylococcus aureus

Indexed keywords

CIPROFLOXACIN; GATIFLOXACIN; LEVOFLOXACIN; NORFLOXACIN; OFLOXACIN; OXACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CODON; CONTROLLED STUDY; GENE LOCUS; GENE MUTATION; GENOTYPE; GRLA GENE; GYRA GENE; HUMAN; IRAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS AUREUS;

EID: 80054022352     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.881920     Document Type: Article

References (25)

1. Brumftt W, Hamilton-Miller JM: The worldwide problem of methicil-lin-resistant Staphylococcus aureus. Drugs Exp Clin Res, 1990; 16: 205-14
2. Emaneini M, Taherikalani M, Eslampour MA et al: Phenotypic and ge-notypic evaluation of aminoglycoside resistance in clinical isolates of staphylococci in Tehran, Iran. Microb Drug Resist, 2009; 15: 129-32
3. Nicholas BD, Bhargave G, Hatipoglu A et al: Preoperative prevalence of methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients undergoing intranasal surgery. Med Sci Monit, 2010; 16(8): CR365-CR368
4. Chambers HF: Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev, 1997; 10: 781-91
5. Hooper DC: Fluoroquinolone resistance among Gram-positive cocci. Lancet Infect Dis, 2002; 2: 530-38
6. Schmitz FJ, Higgins PG, Mayer S et al: Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance. Eur J Clin Microbiol Infect Dis, 2002; 21: 647-59
7. Horii T, Suzuki Y, Takeshita A, Maekawa M: Molecular characterization of 8-methoxyfuoroquinolone resistance in a clinical isolate of methi-cillin-resistant Staphylococcus aureus. Chemotherapy, 2007; 53: 104-9
8. Tanaka M, Wang T, Onodera Y et al: Mechanism of quinolone resistance in Staphylococcus aureus. J Infect Chemother, 2000; 6: 131-39
9. Tanaka M, Onodera Y, Uchida Y, Sato K: Quinolone resistance mutations in the GrlB protein of Staphylococcus aureus. Antimicrob Agents Chemother, 1998; 42: 3044-46
10. Iihara H, Suzuki T. Kawamura Y et al: Emerging multiple mutations and high-level fuoroquinolone resistance in methicillin-resistant Staphylococcus aureus isolated from ocular infections. Diagn Microbiol Infect Dis, 2006; 56: 297-303
11. Fatholahzadeh B, Emaneini M, Gilbert G et al: Staphylococcal cassette chromosome mec (SCCmec) analysis and antimicrobial susceptibility patterns of methicillin-resistant Staphylococcus aureus (MRSA) isolates in Tehran, Iran. Microb Drug Resist, 2008; 14: 217-20
12. rd ed. Philadelphia, PA, USA 2007
13. th ed.), American Society for Microbiology, Washington, DC, 64-76.1999
14. Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. 2011; 31: M100-S21.
15. Fatholahzadeh B, Emaneini M, Aligholi M et al: Molecular characterization of methicillin-resistant Staphylococcus aureus clones from a teaching hospital in Tehran. Jpn J Infect Dis, 2009; 62: 309-11
16. Horii T, Suzuki Y, Monji A et al: Detection of mutations in quinolone resistance-determining regions in levofoxacin- and methicillin-resis-tant Staphylococcus aureus: effects of the mutations on fuoroquino-lone MICs. Diagn Microbiol Infect Dis, 2003; 46: 139-45
17. Schmitz FJ, Jones ME, Hofmann B et al: Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofoxacin MIC. Antimicrob Agents Chemother, 1998; 42: 1249-52
18. Emaneini M, Aligholi M, Hashemi FB et al: Isolation of vancomycin-resistant Staphylococcus aureus in a teaching hospital in Tehran. J Hosp Infect, 2007; 66: 92-93
19. Blumberg HM, Rimland D, Carroll DJ et al: Rapid development of cipro-foxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. J Infect Dis, 1991; 163: 1279-85
20. Marangon FB, Miller D, Muallem MS et al: Ciprofoxacin and levofox-acin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. Am J Ophthalmol, 2004; 137: 453-58
21. Coskun-Ari FF, Bosgelmez-Tinaz G: grlA and gyrA mutations and antimicrobial susceptibility in clinical isolates of ciprofoxacin- methicillin-resistant Staphylococcus aureus. Eur J Med Res, 2008; 13: 366-70
22. Takahata M, Yonezawa M, Kurose S et al: Mutations in the gyrA and grlA genes of quinolone-resistant clinical isolates of methicillin-resis-tant Staphylococcus aureus. J Antimicrob Chemother, 1996; 38: 543-46
23. Yoon EJ, Lee CY, Shim MJ et al: Extended spectrum of quinolone resistance, even to a potential latter third-generation agent, as a result of a minimum of two GrlA and two GyrA alterations in quinolone-resistant Staphylococcus aureus. Chemotherapy, 2010; 56: 153-57
24. Wang T, Tanaka M, Sato K: Detection of grlA and gyrA mutations in 344 Staphylococcus aureus strains. Antimicrob Agents Chemother, 1998; 42: 236-40
25. Noguchi N, Okihara T, Namiki Y et al: Susceptibility and resistance genes to fluoroquinolones in methicillin-resistant Staphylococcus aureus isolated in 2002. Int J Antimicrob Agents, 2005; 25: 374-79